Antoine Sauguet
Overview
Explore the profile of Antoine Sauguet including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
132
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sebbag W, Sauguet A, Demicheli T, Declemy S, Lecorvec T, Brunet J, et al.
J Endovasc Ther
. 2024 Oct;
:15266028241287175.
PMID: 39435996
Objectives: Percutaneous old balloon angioplasty is still the preferred treatment for the treatment of below-the-knee (BTK) arteries in chronic limb-threatening ischemia (CLTI). In the case of a suboptimal angioplasty result,...
2.
Deloose K, Lansink W, Brodmann M, Werner M, Keirse K, Goueffic Y, et al.
JACC Cardiovasc Interv
. 2023 Dec;
16(23):2900-2914.
PMID: 38092496
Background: There is a scarcity of published head-to-head comparisons between different paclitaxel-coated angioplasty balloons. More prospective safety data to support the health care economic reimbursement processes are needed. Objectives: The...
3.
Subramanian V, Sauguet A, Werner M, Sbarzaglia P, Hausegger K, Goyault G, et al.
Expert Rev Med Devices
. 2023 Jul;
20(9):715-720.
PMID: 37486180
Introduction: Radial access is the standard of care for nearly all cardiac catheterization procedures. It improves patient satisfaction, reduces the length of stay, and is associated with fewer complications. However,...
4.
Deloose K, Lansink W, Brodmann M, Werner M, Keirse K, Goueffic Y, et al.
Cardiovasc Intervent Radiol
. 2022 Sep;
45(12):1855-1859.
PMID: 36058996
Purpose: Although effectiveness and safety of many different paclitaxel coated balloons in the treatment of peripheral arterial disease (PAD) are extensively studied, there is a lack of direct head-to-head comparison...
5.
Becquemin J, Haupert S, Issam F, Dubar A, Martelloni Y, Jousset Y, et al.
Eur J Vasc Endovasc Surg
. 2022 Apr;
63(5):781.
PMID: 35365381
No abstract available.
6.
Steiner S, Honton B, Langhoff R, Chiesa R, Kahlberg A, Thieme M, et al.
JACC Cardiovasc Interv
. 2022 Feb;
15(6):618-626.
PMID: 35219622
Objectives: The aim of the study was to assess 24-month efficacy and safety of a novel drug-eluting stent (DES) for femoropopliteal interventions with an innovative stent design and abluminal reservoir...
7.
Left atrial appendage closure for thrombus trapping: the international, multicentre TRAPEUR registry
Sebag F, Garot P, Galea R, De Backer O, Lepillier A, De Meesteer A, et al.
EuroIntervention
. 2021 Nov;
18(1):50-57.
PMID: 34794937
Background: Although the presence of a thrombus contraindicates left atrial appendage closure procedure (LAAC), a previous study reported the feasibility of the thrombus trapping procedure (TTP) technique to overcome this...
8.
Honton B, Sauguet A, Farah B, Gellee S, Riviere L
JACC Case Rep
. 2021 Jul;
2(15):2394-2396.
PMID: 34317178
We report the case of an extended pseudo-subarachnoid hemorrhage (PSAH) related to contrast intracerebral diffusion from blood-brain barrier breakdown on periprocedural percutaneous coronary intervention right corticofrontal ischemic stroke. PSAH is...
9.
Becquemin J, Haupert S, Issam F, Dubar A, Martelloni Y, Jousset Y, et al.
Eur J Vasc Endovasc Surg
. 2020 Oct;
61(1):98-105.
PMID: 33004284
Objective: Endovascular repair is the preferred method of treatment for infrarenal abdominal aortic aneurysms with numerous publications from multiple geographic regions showing excellent patient outcomes. Since the original ACE (Anevrysme...
10.
Goueffic Y, Sauguet A, Desgranges P, Feugier P, Rosset E, Ducasse E, et al.
JACC Cardiovasc Interv
. 2020 Feb;
13(4):447-457.
PMID: 32081238
Objectives: The primary objective of the BATTLE (Bare Metal Stent vs. Paclitaxel Eluting Stent in the Setting of Primary Stenting of Intermediate-Length Femoropopliteal Lesions) trial is to demonstrate the clinical...